ClinicalTrials.gov
public full text
Public Domain
Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults
The main objectives of the trial are to study whether daily treatment with liraglutide improves insulin secretion and glucose metabolism, and whether liraglutide treatment is tolerable and safe in subjects with preclinical type 1 diabetes aged 18-30 years.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Incretin Effect in People With Impaired Fasting Glucose#830519
- Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)#1060161
- The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)#1045638
- Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes#845024
- A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes#432868
Record · ID 842289
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive